Enhancing Collaboration and Anticipating Cardiac Toxicities in Cancer Patients

In recent years, there has been great emphasis placed on the importance of cardio-oncology, with both cardiologists and hematologists highlighting the value of collaboration between specialists when treating patients with hematological malignancies. Furthermore, the 2022 European Society of Cardiology (ESC) cardio-oncology guidelines aim to help healthcare professionals with the treatment and management of cancer therapy-related cardiovascular toxicities (CTR-CVT).

In this podcast, Daniel Lenihan, MD, FACC, Saint Francis Healthcare System, Cape Girardeau, MO, Raul Cordoba, MD, PhD, University Hospital Fundación Jiménez Díaz, Madrid, Spain, and Iskra Pusic, MD, MSCI, Washington University School of Medicine, St. Louis, MO, unravel the critical relevance of cardio-oncology, stressing the significance of multidisciplinary teams (MDTs) and the application of the ESC 2022 guidelines. Discussing their experiences from different healthcare institutions across the globe, the experts underscore the importance of cooperation between cardiologists and hematologists as they navigate difficult medical decisions for patients with specific complications.

The post The importance of cardio-oncology: awareness around the ESC 2022 guidelines & the value of building MDTs appeared first on VJHemOnc.